Medimax Aktiebolag is a Swedish AB based in Stockholm, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 1986, the company has 0 employees and reported revenue of 208,2 tn kr in its latest annual filing.
Bolaget skall tillhandahålla tjänster såsom utvidgad läkarmottagningsverksamhet inkluderande utfärdandet av diverse intyg, hembesök, friskvård och förebyggande vård, bedriva konsultverksamhet och viss försäljning inom det medicinskt-tekniska området samt hantera och förvalta värdepapper, ävensom idka därmed förenlig verksamhet.
In its most recent annual report (2026), Medimax Aktiebolag reported revenue of 208,2 tn kr, a decrease of 9% on the year before. The figures on this page draw on 5 annual filings covering 2022 to 2026. The bottom line showed a net profit of 276,5 tn kr, and the EBITDA margin stood at 79.3%.
At the end of 2026, equity financed 93.4% of the balance sheet, and current assets covered short-term debt 1.2 times.
Frequently asked questions
What is the Org number of Medimax Aktiebolag?
Medimax Aktiebolag is registered with Bolagsverket / SCB under Org 5562880889.
What is the revenue of Medimax Aktiebolag?
Medimax Aktiebolag reported revenue of 208,2 tn kr in 2026.
Who is the CEO of Medimax Aktiebolag?
Henrik Ehrén is the CEO of Medimax Aktiebolag, in role since 2022.
Where is Medimax Aktiebolag headquartered?
Medimax Aktiebolag's registered address is Grev Magnigatan 5.
